MedPath

Emla®

Brand Name: Emla®

Generic Name: Lidocaine hydrochloride + Prilocaine hydrochloride

Active
Registration Number

DR-XY3694

Dosage Form

Cream

Issuance Date

June 1, 2021

Expiry Date

August 1, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25mg/ 25mg (5%)
PackagingTube x 5g (Box of 5's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Local Anesthesia
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Lidocaine hydrochlorideActive
Monograph: Lidocaine
Prilocaine hydrochlorideActive
Monograph: Prilocaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform